Pharma Journalist 9038 posts 0 comments

Pfizer Inc. and BioNTech SE announced that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The…
Read More...

Gilead Sciences, Inc. announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Veklury (remdesivir) as a treatment for SARS-CoV-2…
Read More...

CluePoints, the premier provider of Risk-Based Quality Management (RBQM) and Data Quality Oversight Software for clinical trials, announced that its recently launched complimentary…
Read More...

ZYUS Life Sciences Inc., a company dedicated to improving quality of life through research and leadership in bio-pharmaceuticals and the development of innovative cannabinoid-based…
Read More...

Humanigen, Inc. a clinical stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the company’s proprietary Humaneered anti-human granulocyte…
Read More...

Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced that Cancer Research UK’s Commercial…
Read More...

Enlivex Therapeutics Ltd. announced that an investigator-initiated multi-center Phase II clinical trial of AllocetraTM (formerly referred to as off-the-shelf AllocetraTM) in COVID-19…
Read More...

PTC Therapeutics, Inc. announced that it has entered into an agreement to acquire Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001…
Read More...

Laurent Pharmaceuticals Inc., a Montreal-based biopharmaceutical company, announced that it has obtained the approval from Health Canada to initiate RESOLUTION, a Phase 2 randomized…
Read More...

AVROBIO, Inc. and Magenta Therapeutics announced a research and clinical collaboration agreement to evaluate the potential utility of MGTA-117, Magenta’s novel targeted antibody-drug…
Read More...